Physician

Bradley Elliott Chipps, M.D.

According to 2025 Medicare claims, Bradley Chipps, M.D. (NPI: 1073524740) practices pulmonary disease in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is CAPITAL ALLERGY AND RESPIRATORY DISEASE CENTER A MED CORP (NPI: 1629191267; TIN: 68-0423032) and primary practice location at 95819-3957.

Chipps' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 495 traditional Medicare patients, billed 41,164 HCPCS/CPT codes, and received $1,130,698 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,672 prescription claims across 618 beneficiaries totaling $3,072,536 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 1,650 claims. Open Payments data shows 78 records totaling $35,300. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,054	74,439	$1,529,010
2016	1,015	63,358	$1,441,924
2017	1,016	64,734	$1,437,781
2018	1,082	61,127	$1,627,069
2019	1,090	63,471	$1,764,293
2020	978	57,004	$1,745,618
2021	1,077	61,208	$1,925,625
2022	1,093	81,549	$2,097,061
2023	815	62,351	$1,638,434
2024	495	41,164	$1,130,698

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	724	5,445	$3,139,367
2016	787	6,184	$2,752,999
2017	760	6,246	$2,330,916
2018	728	5,970	$2,613,126
2019	723	5,802	$2,488,407
2020	735	5,780	$2,988,159
2021	811	5,693	$3,796,496
2022	841	6,486	$4,375,778
2023	758	5,747	$4,164,273
2024	618	4,672	$3,072,536

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	645	2,686	$229,254
2016	695	2,750	$290,544
2017	766	2,849	$253,141
2018	879	3,253	$296,985
2019	953	3,334	$331,407
2020	1,080	3,524	$394,637
2021	968	3,124	$281,522
2022	800	2,665	$331,061
2023	726	2,314	$270,885
2024	513	1,650	$200,429

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	353	704	$103
94010	Test to measure expiratory airflow and volume	169	198	$23
95144	Professional service for preparation and provision of single-dose vial of allergen	75	1,693	$13
95117	Professional service for multiple injections of allergen	159	2,062	$10
96160	Administration and interpretation of patient-focused health risk assessment	145	192	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	182	5,096	$678,215
Xolair	Omalizumab	139	3,892	$391,587
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	212	9,480	$191,075
Tezspire	Tezepelumab-Ekko	36	1,008	$145,910
Spiriva Respimat	Tiotropium Bromide	162	8,521	$136,291

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	12	$58,823
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	11	$34,417
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	28	$23,822
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	16	$15,623
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	19	128	$9,086

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	77	$34,134	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,166	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bradley Elliott Chipps, M.D.?

Tedicare shows public-source Medicare data for Bradley Elliott Chipps, M.D. (NPI 1073524740), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bradley Elliott Chipps, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bradley Elliott Chipps, M.D.?

Bradley Elliott Chipps, M.D. is linked to CAPITAL ALLERGY AND RESPIRATORY DISEASE CENTER A MED CORP (billing NPI 1629191267) in the available physician profile data.

Does Bradley Elliott Chipps, M.D. have Open Payments data?

Bradley Elliott Chipps, M.D. has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.